Limaprost Fails in Treating Carpal Tunnel:

Ono Pharmaceutical and Dainippon Sumitomo Pharma, in a joint study, have decided to hault the production of the drug Limaprost for the treatment of carpal tunnel syndrome.

USAMRUK Malaria Diagnostics and Control Center of Excellence microscopy training -  Nigeria, Africa 092009

Image by US Army Africa via Flickr

Both companies have been jointly developing limaprost for an additional indication of carpal-tunnel syndrome and conducted a phase 2 study to investigate the efficacy of the drug. However, the study failed to demonstrate the anticipated efficacy. Both companies therefore decided to discontinue the development of limaprost for the additional indication of carpal-tunnel syndrome….More at Discontinuation of Development for the Additional Indication of Carpal-Tunnel … – PharmaLive (press release) (subscription)

What is Carpal Tunnel Syndrome?

[Reference] Carpal-tunnel syndrome is a neurological disorder mainly associated with numbness and pain in the hands and fingers. It has been reported that it results from compression, from any cause on the median nerve of the base of the hands, and is involved with the reduction in blood flow of the compressed nerve tissue….More at Discontinuation of Development for the Additional Indication of Carpal-Tunnel … – PharmaLive (press release) (subscription)